Envestnet Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Envestnet Asset Management's IRMD Position: Q1 2026 in Review
Envestnet Asset Management increased its iRadimed (IRMD) stake by 19% in Q1 2026, buying an estimated $1.2M and bringing the position to 75,460 shares worth $7.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2054.
Envestnet Asset Management first reported a position in IRMD in Q3 2016 and has held it in 13 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Envestnet Asset Management held 75,460 shares of iRadimed worth $7.26M as of Q1 2026.
- Envestnet Asset Management bought 12,036 iRadimed shares in Q1 2026, an estimated $1.2M.
- iRadimed made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #2054 holding.
- Envestnet Asset Management first reported a position in iRadimed in Q3 2016 and has held it in 13 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.